Comparison of the vaginal tablet of vagiclean and metronidazole on Bacterial vaginosis
Phase 3
Recruiting
- Conditions
- Bacterial vaginosis.N70-N77Inflammatory diseases of female pelvic organs
- Registration Number
- IRCT20220512054829N1
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 106
Inclusion Criteria
• Women in the age range of 18 to 49 years•
Women who are sexually active•
Bacterial vaginitis has been diagnosed in them.
Exclusion Criteria
• Pregnancy and lactation
• The presence of an intrauterine device ,
Use of specific medications such as immunosuppressive drugs and broad-spectrum antibiotics
• Having certain diseases such as liver, nerve, heart, kidney and blood dyscrasias and diabetes
Use of antiprostaglandins
• Complications from drug use or drug allergies
• Vaginal candidiasis and Trichomonas vaginalis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bacterial vaginitis. Timepoint: Before intervention, 5th days of intervention, 10th days of intervention. Method of measurement: Observation of symptoms.;Clinical symptoms (dysuria, itching, lower abdominal pain, burning, dysparonia, foul-smelling discharge, vaginal discharge). Timepoint: Before intervention, 5th days of intervention, 10th days of intervention. Method of measurement: Observation of symptoms.;Positive Amsel criteria (KOH test, PH test, clinical signs, smear test). Timepoint: Before intervention, 5th days of intervention, 10th days of intervention. Method of measurement: results of laboratory symptoms.
- Secondary Outcome Measures
Name Time Method Dysuria, itching, lower abdominal pain, burning, dysparonia, foul-smelling discharge, vaginal discharge. Timepoint: Before intervention, 5th day of intervention, 10th day of intervention. Method of measurement: Clinical interview with the patient.;Positive Amsel criteria (KOH test, PH test, clinical signs, smear test). Timepoint: Before intervention, 5th day of intervention, 10th day of intervention. Method of measurement: Observation of symptoms.